Multi-level and Intersectional Stigma and other Social determinant Effects on TB case Detection, care, and treatment outcomes: The MISSED TB Outcomes Study Grant uri icon

abstract

  • Dr. Kipp will serve as a co-principal investigator on the project "Multi-level and Intersectional Stigma and other Social determinant Effects on TB case Detection, care, and treatment outcomes: The MISSED TB Outcomes Study". The goal of the project is to identify social determinants that prevent TB-infected individuals from testing for TB and remaining in TB treatment if diagnosed. Data will be collected from individual-, household, and community-level sources and both quantitative and qualitative methods will be utilized. Results of the study will identify individual and/or community-level factors that should be targeted for interventions. Dr. Kipp is an Assistant Professor in the Department of Public Health at East Carolina University's Brody School of Medicine and is Adjunct Assistant Professor in the Department of Medicine, Division of Epidemiology, at Vanderbilt University Medical Center. He remains affiliated with the Vanderbilt Institute for Global Health at Vanderbilt University. Dr. Kipp is an epidemiologist with research interests in psychosocial factors that affect TB and HIV outcomes, with experience in TB and HIV stigma and retention in care internationally (Thailand, Peru) and in the US. He has extensive training in the methodologies of study design and data analysis and has recently added qualitative study methods to his repertoire. He helped direct a mixed-methods study with the World Health Organization that examined factors affecting child survival in Africa, including data collection in four different countries. He is therefore familiar with the challenges of conducting multi-site research in an African setting. Dr. Kipp and Dr. Medina-Marino (co-PI) have been working together to validate TB stigma measures in South Africa in anticipation of the current proposal. Dr. Kipp has also received funding from NIH/NIDA (PI), SAMHSA (Co-I), and DHHS/OMH (Co-I) to conduct substance use research in HIV infected and uninfected individuals. Dr. Kipp will assist with the study design and oversee the quantitative data collection and analysis components. He will work closely with Co-PI Dr. Medina-Marino in finalizing the study design and data collection, with Co-I Dr. Preacher in finalizing the statistical analysis plan, and with Co-I Dr. Daftary in designing the qualitative component of the study. Drs. Kipp and Audet will work together and closely with Drs. Medina-Marino and Daftary to identify intervention targets based on the study findings and lay out a process to select and adapt or develop an appropriate intervention in years 4 and 5 of the project.

date/time interval

  • December 2020 - November 2024